RT Journal Article
SR Electronic
T1 Evaluation of the Implementation of the 4C Mortality Score in United Kingdom hospitals during the second pandemic wave
JF medRxiv
FD Cold Spring Harbor Laboratory Press
SP 2021.12.18.21268003
DO 10.1101/2021.12.18.21268003
A1 Blunsum, Andrew E.
A1 Perkins, Jonathan S.
A1 Arshad, Areeb
A1 Bajpai, Sukrit
A1 Barclay-Elliott, Karen
A1 Brito-Mutunayagam, Sanjita
A1 Brooks, Rebecca
A1 Chan, Terrence
A1 Coates, Dominic J. G.
A1 Corobana, Alina
A1 Crocker-Buqué, Tim
A1 Evans, Terry J.
A1 Gordon-Brown, Jasmine
A1 Hack, Berkin
A1 Hiles, Heather
A1 Khanijau, Aakash
A1 Lalwani, Salina
A1 Leong, Clare
A1 MacKay, Kirsty
A1 Macrae, Catriona
A1 Martin, Bryony
A1 Martin, Christopher A.
A1 McKemey, Emily
A1 Nazareth, Joshua
A1 Pan, Daniel
A1 Scopazzini, Marcello
A1 Simons, David
A1 Swinhoe, Sophie
A1 Thomas, Julia
A1 Thorburn, Fiona
A1 Walpole, Sarah
A1 Warne, Esmie
A1 Wilson, Rory
A1 MacConnachie, Alisdair
A1 Ho, Antonia
YR 2022
UL http://medrxiv.org/content/early/2022/01/04/2021.12.18.21268003.abstract
AB The 4C Mortality Score (4C Score) was designed to risk stratify hospitalised patients with COVID-19. We assessed inclusion of 4C Score in COVID-19 management guidance and its documentation in patients’ case notes in January 2021 in UK hospitals. 4C Score was included within guidance by 50% of sites, though score documentation in case notes was highly variable. Higher documentation of 4C Score was associated with score integration within admissions proformas, inclusion of 4C Score variables or link to online calculator, and management decisions. Integration of 4C Score within clinical pathways may encourage more widespread use.Competing Interest StatementAH has received grant funding from UKRI for work that included the development and validation of 4C Mortality Score. Presented data included in this manuscript at the St. Andrew's Day Symposium: Updates on Acute Medicine, Royal College of Physicians Edinburgh.Funding StatementThe authors have not declared a specific grant for this research from any funding agency in the public, commercial or not-for-project sectors.Author DeclarationsI confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.YesThe details of the IRB/oversight body that provided approval or exemption for the research described are given below:This study was classified as service evaluation by the West of Scotland Research Ethics Committee. Caldicott Guardian approval was obtained at each participating site. Details of the study protocol are included as an online AppendixI confirm that all necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived, and that any patient/participant/sample identifiers included were not known to anyone (e.g., hospital staff, patients or participants themselves) outside the research group so cannot be used to identify individuals.YesI understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).YesI have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.YesAll data produced in the present study are available upon reasonable request to the authors